DNA

Ginkgo Bioworks Holdings Inc

9.71

Oct 22 • 3:59 PM ET -0.30 (-3.00%)

9.66

Aftermarket • 7:47 PM ET -0.05 (-0.51%)

Healthcare Biotechnology USA Small NYSE

Peers: ABSI TWST RXRX ABCL GENB CDXS MRVI NAUT SEER DYAI

| Held by: VTI IWM VXF IWN THNQ IBB VTWO KOMP SCHA DFAS

Scroll to Statements

Index	RUT
Market Cap	653.88M
Enterprise Value	752.91M
Income	-315.31M
Sales	111.86M
Book/sh	6.92
Cash/sh	4.53
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	485
IPO	Apr 19, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	5.85
P/B	1.40
P/C	2.14
P/FCF	-
EV/EBITDA	-
EV/Sales	6.73
Quick Ratio	4.57
Current Ratio	4.57
Debt/Eq	0.96
LT Debt/Eq	0.96
Option/Short	Yes / Yes

EPS (ttm)	-5.44
EPS next Y	-3.37
EPS next Q	-0.68
EPS this Y	30.67%
EPS next Y	13.94%
EPS next 5Y	29.22%
EPS past 3/5Y	51.73% -7.49%
Sales past 3/5Y	-29.11% 17.29%
EPS Y/Y TTM	7.05%
Sales Y/Y TTM	-51.54%
EPS Q/Q	-4.34%
Sales Q/Q	-59.37%
Earnings	Aug 05 AMC
EPS/Sales Surpr.	16.20% -16.19%

Insider Own	23.67%
Insider Trans	-0.86%
Inst Own	58.72%
Inst Trans	8.73%
ROA	-26.55%
ROE	-57.08%
ROIC	-38.25%
Gross Margin	34.59%
Oper. Margin	-257.99%
Profit Margin	-281.87%
SMA20	-15.83%
SMA50	7.67%
SMA200	13.87%
Trades

Shs Outstand	52.32M
Shs Float	49.11M
Short Float	14.90%
Short Ratio	3.62
Short Interest	7.32M
52W High	18.22 -46.71%
52W Low	5.37 80.82%
Volatility	9.61% 13.79%
ATR (14)	1.21
RSI (14)	45.53
Beta	1.73
Rel Volume	0.98
Avg Volume	2.02M
Volume	1,979,214

Perf Week	-17.43%
Perf Month	13.17%
Perf Quarter	31.93%
Perf Half Y	26.10%
Perf YTD	16.85%
Perf Year	-24.02%
Perf 3Y	-84.54%
Perf 5Y	-98.15%
Perf 10Y	-
Recom	3.67
Target Price	8.00
Prev Close	10.01
Price	9.71
Change %	-3.00%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-07-26	Downgrade	TD Cowen	Buy → Hold	$9
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform	$3.50 → $2.50
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell	$3 → $1.25
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy	$6
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight	$5
May-18-22	Downgrade	BofA Securities	Neutral → Underperform	$3
Mar-02-22	Resumed	Cowen	Outperform	$12
Feb-23-22	Initiated	Goldman	Neutral	$7
Feb-01-22	Initiated	BofA Securities	Neutral	$6
Jan-28-22	Initiated	BofA Securities	Buy	$8
Jan-07-22	Initiated	BTIG Research	Buy	$12
Nov-29-21	Initiated	Jefferies	Buy	$16
Oct-13-21	Initiated	Raymond James	Outperform	$14.50
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy	$14

Show Previous Ratings

Oct-08-26 04:10PM	Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program (Business Wire) +14.64%
06:00AM	Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop (PR Newswire)
Sep-25-26 06:29PM	What Needs To Be True To Buy Twist Bioscience Stock Now? (Trefis)
Sep-16-26 09:52AM	Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data (Business Wire)
Sep-10-26 08:00AM	Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines (Business Wire)
12:19AM	Loading…
Aug-07-26 12:19AM	Ginkgo Bioworks Holdings, Inc. Q2 2026 Earnings Call Summary (Moby) -6.24%
May-26-26 12:33PM	Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery (PR Newswire)
May-12-26 10:30AM	The $59B Quiet Shift Reshaping How Patients Access Care (PR Newswire)
May-08-26 08:30AM	Ginkgo Bioworks Holdings, Inc. Q1 2026 Earnings Call Summary (Moby) -13.47%
May-07-26 04:05PM	Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab (PR Newswire)
May-06-26 09:29AM	Earnings To Watch: Ginkgo Bioworks Holdings Inc (DNA) Reports Q1 2026 Result (GuruFocus.com)
Apr-30-26 08:01AM	Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation (PR Newswire) +12.80%
Mar-07-26 03:01PM	Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen (Benzinga)
Mar-02-26 08:00AM	Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure (PR Newswire)
Feb-28-26 12:07AM	Ginkgo Bioworks Q4 Earnings Call Highlights (MarketBeat)
08:02PM	Loading…
Feb-27-26 08:02PM	Ginkgo Bioworks Holdings Inc (DNA) Q4 2025 Earnings Call Highlights: Strategic Shifts and ... (GuruFocus.com) -30.48%
11:50AM	Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter (Benzinga)
08:30AM	Ginkgo Bioworks Holdings, Inc. Q4 2025 Earnings Call Summary (Moby)
Feb-26-26 04:26PM	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business (PR Newswire)
Feb-25-26 07:35AM	Ginkgo Bioworks Holdings Inc (DNA) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +5.87%
Feb-19-26 08:00AM	Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation (PR Newswire) +8.27%
Feb-18-26 08:00AM	Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products (PR Newswire)
Feb-17-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts (Zacks)
Feb-10-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks) -9.06%
Feb-06-26 06:26AM	Ginkgo, OpenAI Cut Protein Costs by 40% (GuruFocus.com) +21.39%
Feb-05-26 02:00PM	Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark (PR Newswire)
Feb-04-26 06:15PM	Why Ginkgo Bioworks Holdings, Inc. (DNA) Dipped More Than Broader Market Today (Zacks) -5.92%
Jan-29-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Declines More Than Market: Some Information for Investors (Zacks)
Jan-23-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -6.36%
Jan-14-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
08:00AM	Loading…
Jan-13-26 08:00AM	Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-08-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts (Zacks) -5.72%
Dec-31-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts (Zacks)
Dec-22-25 01:21PM	Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach (PR Newswire) +8.52%
Dec-17-25 08:00AM	Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment (PR Newswire)
Dec-09-25 08:00AM	Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety (PR Newswire)
Dec-05-25 08:33AM	Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High-Throughput Phenotyping Platform for DOE's M2PC (PR Newswire)
Dec-03-25 08:00AM	STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy (PR Newswire)
Nov-18-25 08:00AM	Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health (PR Newswire)
Nov-07-25 04:00AM	Ginkgo Bioworks Holdings Inc (DNA) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst ... (GuruFocus.com) -20.80%
Nov-06-25 04:05PM	Ginkgo Bioworks Reports Third Quarter 2025 Financial Results (PR Newswire)
Nov-05-25 07:46AM	Earnings To Watch: Ginkgo Bioworks Holdings Inc (DNA) Reports Q3 2025 Result (GuruFocus.com)
Nov-03-25 08:00AM	Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium (PR Newswire)
Oct-31-25 08:00AM	Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture (PR Newswire) +8.16%
Oct-30-25 04:05PM	Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation (PR Newswire)
Oct-28-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts (Zacks)
Oct-23-25 08:00AM	Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program (PR Newswire)
Oct-22-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
Oct-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Dips More Than Broader Market: What You Should Know (Zacks) -12.37%
Oct-09-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks) -5.28% -11.29%
Oct-03-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know (Zacks) -7.87%
Sep-30-25 12:39PM	Ginkgo Bioworks Holdings Stock Scores RS Rating Upgrade (Investor's Business Daily) +10.20%
Sep-23-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Advances While Market Declines: Some Information for Investors (Zacks) -6.64%
Sep-04-25 08:00AM	Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium (Business Wire)
Aug-29-25 04:05PM	Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions (PR Newswire) -13.02%
Aug-20-25 08:01AM	Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry (PR Newswire)
Aug-13-25 09:30AM	Ginkgo Bioworks Holdings, Inc. (DNA) Recently Broke Out Above the 50-Day Moving Average (Zacks) +14.71%
Aug-12-25 08:01AM	Ginkgo Automation Appoints Brian?O'Sullivan as Head of Commercial to Accelerate External Growth (PR Newswire)
Aug-08-25 03:46AM	Ginkgo Bioworks Holdings Inc (DNA) Q2 2025 Earnings Call Highlights: Strategic Cost Management ... (GuruFocus.com) -8.69%
Aug-07-25 05:01PM	Ginkgo Bioworks Reports Second Quarter 2025 Financial Results (PR Newswire)
Jul-31-25 09:30AM	Ginkgo Bioworks awarded $4.66M contract by PNNL (TipRanks)
08:01AM	Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation (PR Newswire)
Jul-30-25 09:01AM	Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy (PR Newswire)
Jul-25-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks) -6.31%
Jul-17-25 09:01AM	Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors (PR Newswire)
Jul-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Outperforms Broader Market: What You Need to Know (Zacks)
Jul-10-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why (Zacks) -7.51%
Jul-01-25 06:53AM	Ginkgo Bioworks (DNA) Soars 18.9%: Is Further Upside Left in the Stock? (Zacks)
Jun-25-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves 1.41%: What You Should Know (Zacks)
May-21-25 04:05PM	Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer (PR Newswire) -7.38% -7.43%
May-08-25 11:36PM	Ginkgo Bioworks Holdings, Inc. (DNA): Among Nicholas J. Pritzker's Stock Picks with Huge Upside Potential (Insider Monkey) +6.35%
08:00AM	Twist Bioscience and Ginkgo Bioworks Revise Collaboration (Business Wire)
May-06-25 06:30PM	Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.79% +14.73%
05:00PM	Ginkgo Bioworks Reports First Quarter 2025 Financial Results (PR Newswire)
May-01-25 07:50AM	Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -5.56%
Apr-30-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
09:00AM	Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors (PR Newswire)
Apr-29-25 04:00PM	Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation (PR Newswire) -7.98%
Apr-23-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
Apr-22-25 09:00AM	Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation (PR Newswire)
09:00AM	Ginkgo Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation (PR Newswire)
Apr-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -1.94%: What You Should Know (Zacks)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha) +11.23%
Apr-10-25 09:55AM	Wall Street Analysts Think Ginkgo Bioworks (DNA) Could Surge 41.59%: Read This Before Placing a Bet (Zacks) +7.67%
09:00AM	Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain (PR Newswire)
Apr-01-25 10:26AM	Is Ginkgo Bioworks Holdings, Inc. (DNA) the Best Gene-Editing Stock to Buy? (Insider Monkey)
09:35AM	Here's Why Ginkgo Bioworks (DNA) is Poised for a Turnaround After Losing -28.84% in 4 Weeks (Zacks)
Mar-27-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) -7.13%
Mar-21-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Surpasses Market Returns: Some Facts Worth Knowing (Zacks) +5.91%
Mar-14-25 09:35AM	After Plunging -52.33% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) (Zacks) +7.89%
Mar-05-25 12:00PM	Ginkgo Bioworks (DNA) Upgraded to Buy: Here's Why (Zacks)
Feb-25-25 05:00PM	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire) -11.47%
Feb-21-25 09:00AM	Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab (PR Newswire) -5.34%
Feb-20-25 08:01AM	Ginkgo Bioworks Partners with HaDEA in Up to 24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care (PR Newswire) -9.86%
Feb-18-25 08:00AM	Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation (PR Newswire) -6.52%
Feb-06-25 08:01AM	Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series (PR Newswire) -16.38%
Jan-29-25 12:00PM	Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jan-23-25 08:01AM	Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC) (PR Newswire)
Jan-13-25 08:01AM	Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors (PR Newswire) -9.41%
Jan-09-25 11:38AM	Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Coen Steven P.	See remarks	Oct 19 '26	Sale	10.14	766	7,770	50,168	Oct 21 04:07 PM
Canton Barry	10% Owner	Oct 19 '26	Sale	10.14	22,369	226,889	453,951	Oct 21 04:06 PM
Canton Barry	10% Owner	Oct 19 '26	Sale	10.14	18,803	190,719	356,329	Oct 21 04:06 PM
Shetty Reshma P.	See remarks	Oct 19 '26	Sale	10.14	22,369	226,889	453,951	Oct 21 04:06 PM
Shetty Reshma P.	See remarks	Oct 19 '26	Sale	10.14	18,803	190,719	356,329	Oct 21 04:06 PM
Kelly Jason R	See remarks	Oct 19 '26	Sale	10.14	45,682	463,353	129,065	Oct 21 04:05 PM
Coen Steven P.	Officer	Oct 19 '26	Proposed Sale	10.14	766	7,769		Oct 19 03:58 PM
Canton Barry	Officer	Oct 19 '26	Proposed Sale	10.14	18,803	190,711		Oct 19 03:47 PM
Che Austin	Officer	Oct 19 '26	Proposed Sale	10.14	16,058	162,870		Oct 19 03:45 PM
Shetty Reshma P.	Officer	Oct 19 '26	Proposed Sale	10.14	22,369	226,880		Oct 19 03:42 PM
Kelly Jason R	Officer	Oct 19 '26	Proposed Sale	10.14	45,682	463,334		Oct 19 03:38 PM
Che Austin	Officer	Oct 19 '26	Proposed Sale	10.38	2,200	22,836		Oct 19 10:08 AM
Coen Steven P.	See remarks	Oct 05 '26	Sale	15.00	2,403	36,045	49,448	Oct 07 05:00 PM
Coen Steven P.	Officer	Oct 05 '26	Proposed Sale	15.00	2,403	36,045		Oct 05 02:04 PM
Che Austin	Officer	Sep 17 '26	Proposed Sale	7.29	2,200	16,038		Sep 17 09:52 AM
HENRY CHRISTIAN O	Director	Sep 15 '26	Sale	7.08	5,000	35,405	19,310	Sep 16 04:06 PM
HENRY CHRISTIAN O	Director	Sep 15 '26	Proposed Sale	7.08	5,000	35,406		Sep 15 11:47 AM
Coen Steven P.	See remarks	Aug 24 '26	Sale	6.98	330	2,302	51,851	Aug 25 05:01 PM
Coen Steven P.	Officer	Aug 24 '26	Proposed Sale	6.98	330	2,302		Aug 24 03:32 PM
Che Austin	Officer	Aug 17 '26	Proposed Sale	6.66	2,200	14,652		Aug 17 12:18 PM
Coen Steven P.	See remarks	Jul 17 '26	Sale	7.90	752	5,943	51,438	Jul 20 05:00 PM
Coen Steven P.	Officer	Jul 17 '26	Proposed Sale	7.90	752	5,943		Jul 17 04:42 PM
Che Austin	Officer	Jun 10 '26	Proposed Sale	8.06	2,200	17,732		Jun 10 11:20 AM
Coen Steven P.	See remarks	May 22 '26	Sale	8.33	307	2,559	50,704	May 26 05:04 PM
Coen Steven P.	Officer	May 22 '26	Proposed Sale	8.33	307	2,559		May 22 03:25 PM
Che Austin	Officer	May 13 '26	Proposed Sale	8.28	2,200	18,216		May 13 10:39 AM
Coen Steven P.	See remarks	Apr 17 '26	Sale	7.95	324	2,576	50,268	Apr 20 05:02 PM
Coen Steven P.	Officer	Apr 17 '26	Proposed Sale	7.95	324	2,576		Apr 17 03:37 PM
Che Austin	Officer	Apr 15 '26	Proposed Sale	7.78	2,200	17,116		Apr 15 09:37 AM
Coen Steven P.	See remarks	Apr 13 '26	Sale	6.41	33,171	212,759	49,849	Apr 14 05:00 PM
Canton Barry	10% Owner	Apr 10 '26	Sale	6.43	124,727	802,494	436,422	Apr 13 05:00 PM
Shetty Reshma P.	See remarks	Apr 10 '26	Sale	6.43	124,727	802,494	436,422	Apr 13 05:00 PM
Coen Steven P.	Officer	Apr 13 '26	Proposed Sale	6.41	33,171	212,762		Apr 13 03:17 PM
Che Austin	Officer	Apr 13 '26	Proposed Sale	6.41	40,893	262,292		Apr 13 03:16 PM
Shetty Reshma P.	See remarks	Apr 08 '26	Sale	6.93	13,155	91,164	351,684	Apr 10 05:02 PM
Shetty Reshma P.	See remarks	Apr 09 '26	Sale	6.40	13,116	83,903	338,568	Apr 10 05:02 PM
Canton Barry	10% Owner	Apr 08 '26	Sale	6.93	13,155	91,164	351,684	Apr 10 05:01 PM
Canton Barry	10% Owner	Apr 09 '26	Sale	6.40	13,116	83,903	338,568	Apr 10 05:01 PM
Kelly Jason R	See remarks	Apr 09 '26	Sale	6.40	109,767	702,179	316,483	Apr 10 05:01 PM
Kelly Jason R	See remarks	Apr 08 '26	Sale	6.93	97,015	672,314	426,250	Apr 10 05:01 PM
Shetty Reshma P.	Officer	Apr 10 '26	Proposed Sale	6.43	124,727	802,531		Apr 10 03:46 PM
Canton Barry	Officer	Apr 09 '26	Proposed Sale	6.40	13,116	83,906		Apr 09 04:20 PM
Kelly Jason R	Officer	Apr 09 '26	Proposed Sale	6.40	109,767	702,201		Apr 09 04:13 PM
Kelly Jason R	Officer	Apr 08 '26	Proposed Sale	6.93	97,015	672,343		Apr 08 04:14 PM
Canton Barry	Officer	Apr 08 '26	Proposed Sale	6.93	13,155	91,168		Apr 08 04:14 PM
Coen Steven P.	See remarks	Mar 16 '26	Sale	6.74	708	4,768	9,099	Mar 18 05:00 PM
Coen Steven P.	Officer	Mar 16 '26	Proposed Sale	6.74	708	4,769		Mar 16 04:13 PM
Che Austin	Officer	Mar 11 '26	Proposed Sale	6.31	2,200	13,882		Mar 11 10:14 AM
Che Austin	Officer	Feb 04 '26	Proposed Sale	8.80	2,200	19,360		Feb 04 09:52 AM
Coen Steven P.	See remarks	Jan 20 '26	Sale	8.92	972	8,667	8,321	Jan 22 04:12 PM
Coen Steven P.	Officer	Jan 20 '26	Proposed Sale	8.92	972	8,667		Jan 20 04:15 PM
Che Austin	Officer	Jan 07 '26	Proposed Sale	9.16	2,200	20,152		Jan 07 10:09 AM
Coen Steven P.	See remarks	Dec 15 '25	Sale	8.89	736	6,540	7,488	Dec 16 05:11 PM
Coen Steven P.	Officer	Dec 15 '25	Proposed Sale	8.89	736	6,540		Dec 15 04:20 PM
Che Austin	Officer	Dec 10 '25	Proposed Sale	9.54	2,200	20,988		Dec 10 11:09 AM
Che Austin	Officer	Nov 12 '25	Proposed Sale	8.50	2,200	18,700		Nov 12 10:06 AM

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Co-FounderDr. Jason Kelly Ph.D.

Co-FounderDr. Reshma P. Shetty

Chief Financial OfficerMr. Steven P. Coen CPA

FounderMr. Thomas Knight Jr.

Co-Founder & Head of StrategyMr. Austin Che Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DNA

Ginkgo Bioworks Holdings Inc

Upgrade your Finviz experience